VeriMomБезопасен ли chamomilla recutita flower/leaf extract при беременности?
No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS/SCCS-like or CIR conclusion indicating reproductive hazard; CIR has assessed chamomile/Chamomilla extracts as safe as used in cosmetics. Although components (flavonoids such as apigenin) show weak in vitro estrogenic activity in some studies, there is no convincing in vivo reproductive or teratogenic evidence to raise hazard scoring, so hazard and mechanism are scored 0; low but measurable dermal exposure from topical cosmetic use is scored e=1 (PubChem/CosIng product composition and typical extract constituents suggest small molecule components able to be absorbed at low levels).
Pregnancy-safe products containing chamomilla recutita flower/leaf extract
Related ingredients
Frequently asked questions
- Безопасен ли chamomilla recutita flower/leaf extract при беременности?
- No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS/SCCS-like or CIR conclusion indicating reproductive hazard; CIR has assessed chamomile/Chamomilla extracts as safe as used in cosmetics. Although components (flavonoids such as apigenin) show weak in vitro estrogenic activity in some studies, there is no convincing in vivo reproductive or teratogenic evidence to raise hazard scoring, so hazard and mechanism are scored 0; low but measurable dermal exposure from topical cosmetic use is scored e=1 (PubChem/CosIng product composition and typical extract constituents suggest small molecule components able to be absorbed at low levels).
- Безопасен ли chamomilla recutita flower/leaf extract при грудном вскармливании?
- Same rationale as pregnancy: no regulatory reproductive classification or CIR/SCCS contraindication for topical cosmetic use. Low but measurable maternal dermal absorption is possible; systemic transfer into milk is not demonstrated for cosmetic topical use. Breastfeeding exposure therefore scored as low (e=1).
- Безопасен ли chamomilla recutita flower/leaf extract для кожи малыша?
- No infant-specific safety signals or regulatory reproductive/ developmental classifications. Because infant skin has a higher surface-area-to-weight ratio and a less mature barrier, exposure score is increased by +1 versus adults (adult e=1 → infant e=2), although there are no data showing specific harm to 0–3 year olds from topical chamomile extracts used cosmetically. CIR assessment supports safety as used.
- Как VeriMom оценивает chamomilla recutita flower/leaf extract?
- VeriMom оценивает chamomilla recutita flower/leaf extract в 93/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы chamomilla recutita flower/leaf extract при беременности?
- См. наш список безопасных альтернатив chamomilla recutita flower/leaf extract с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.